# Airvo 3 Respiratory Rate Validation Study

> **NCT06329609** · NA · UNKNOWN · sponsor: **Fisher and Paykel Healthcare** · enrollment: 60 (estimated)

## Conditions studied

- COPD
- Healthy Volunteers

## Interventions

- **DEVICE:** Airvo 3 with respiratory rate algorithm

## Key facts

- **NCT ID:** NCT06329609
- **Lead sponsor:** Fisher and Paykel Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06329609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06329609, "Airvo 3 Respiratory Rate Validation Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06329609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*